Menthol Inhalation to Reduce Respiratory Discomfort and Enhance Exercise Performance

Project Overview & Value Proposition

1. What It Is A physiological strategy and delivery mechanism using targeted, continuous menthol/mint inhalation to reduce respiratory discomfort and enhance exercise performance during sustained physical activity. Unlike passive or static aromatic products, this solution is tailored for the high-airflow, humid environment of active exertion.

2. Why It Matters The Clinical & Performance Problem: During intense or prolonged exercise, athletes experience high ventilation rates, leading to respiratory discomfort (dyspnea) that directly limits exercise capacity and performance. Beyond athletics, respiratory discomfort is a primary limiting factor for exercise tolerance across clinical and sub-clinical populations, including aging adults, individuals with obesity, and patients with chronic respiratory conditions.

While our primary validated data focuses on well-trained athletes, the underlying physiological mechanism—trigeminal cooling via TRPM8 activation—suggests high potential for broader applications in clinical exercise tolerance and general wellness.

The Market Gap: Existing menthol products (ointments, nasal sticks, lozenges) are designed for static use and require stopping activity to re-apply. As the menthol effects is not sustained, continous inhalation is needed. Therefore, athletes lack a hands-free, continuous-delivery mechanism optimized for high-ventilation conditions.

The Opportunity: Unlocks a new "Active Performance" category within the global sports and wellness market by leveraging a trusted, universally recognized ingredient (menthol) for real-time exercise performance optimization.

3. How It Works Physiological Mechanism: Menthol acts as an agonist on cold-sensitive TRPM8 receptors in the upper respiratory tract. This stimulation trigeminally triggers a sensation of increased airflow and cooling, directly dampening the perception of respiratory discomfort (dyspnea) and reducing central perceived effort during exercise, without changing respiratory, cardiovascular or metabolic responses to exercise. It is a neurophysiological manipulation.

Delivery Concept: Mint is delivered via a specialized continuous-release substrate that maintains precise, non-irritating vapor concentrations despite high breathing rates and moisture.

4. Proof to Date In Vivo Human Validation: Controlled laboratory trial conducted with well-trained athletes during running.

Key Findings: Demonstrated statistically significant reductions in respiratory discomfort and improvements in time-to-exhaustion running performance under targeted menthol inhalation conditions.

Peer-Reviewed Recognition: The complete study and findings have been accepted for publication in the European Journal of Sport Science.

5. Next Steps & Collaboration Goals Co-Development & Prototyping: Partner with an industry leader to engineer, design, and scale the physical delivery device/substrate (e.g., mask insert, wearable difuser, or wearable matrix).

Physiological Dose-Response Optimization: Conduct follow-up validation trials in our university laboratory to determine optimal vapor concentrations, release rates, and long-duration efficacy for active commercial use.

Commercialization & Licensing: License/transfer the underlying concept and know-how for market entry under a leading global consumer health/sports brand.